Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2780369 Title: ANTICORPS ANTI-ADRENOMEDULLINE (ADM) OU FRAGMENT D'ANTICORPS ANTI-ADM OU ECHAFAUDAGE NON-IG ANTI-ADM POUR LA PREVENTION OU LA REDUCTION D'UN DYSFONCTIONNEMENT ORGANIQUE OU D'UNE INSUFFISANCE ORGANIQUE CHEZ UN PATIENT ATTEINT D'UNE MALADIE CHRONIQUE OU AIGUE OU UN D'ETAT AIGU

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
127846319
WO application number:
EP2012072930
Type:
European patent granted for BE
Status:
Open
Publication number:
2780369
WO publication number:
WO2013072511
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
16/11/2012
Grant date:
13/03/2019
EP publication date:
24/09/2014
WO publication date:
23/05/2013
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
13/03/2019
EP B1 publication date:
13/03/2019
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
16/11/2032

Applicant

Name:
AdrenoMed AG
Legal Form:
From:
13/03/2019
Address:
Neuendorfstrasse 15a, 16761 Hennigsdorf, Germany (DE)
To:

Agent

Name:
POWIS de TENBOSSCHE Roland
Legal Form:
From:
17/05/2019
Address:
Boulevard Général Wahis 15, 1030, BRUXELLES, Belgium (BE)
To:

Inventor

Name:
BERGMANN, Andreas
Legal Form:
Address:
13465 Berlin, Germany (DE)

Priority

1

Priority patent number:
12160014
Priority date:
16/03/2012
Priority country:
European Patent Office (EPO) (EP)

2

Priority patent number:
11189447
Priority date:
16/11/2011
Priority country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 39/395; A61P 9/00; A61P 13/12; A61P 31/00; C07K 16/26;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2019/08
Publication date:
02/05/2019
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

1

Issue number:
201911
Publication date:
13/03/2019
Description:
Grant (B1)

2

Issue number:
201916
Publication date:
17/04/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual fee

Annual fee(s) Due Date:
30/11/2026
Annual fee number:
15
Annual fee amount:
360 Euro
Expected payer:
Last annual fee payment date:
18/11/2025
Last annual fee paid number:
14
Last annual fee paid amount:
320 Euro
Payer:
PAVIS GmbH
Filing date Document type Publication Type Document Description Number of pages File Type
17/05/2019 Incoming Correspondence (Post) 1 PDF /9/8/9/9/2/0721829989/docs/127846319_0_incomingcorrespondencepaper_20190522_034031314.pdf